BioSpace News Archive

Biotech Bay

Landmark Study Released from Stanford Medical School Reveals First Ever Predictive Model for Uncontrolled Type 2 Diabetes Mellitus Related to Social Determinants

Dr. Sanjay Basu and Dr. Rajiv Narayanaswamy, in conjunction with Stanford Medical School, recently released an article in an August issue of Medical Care that addresses social determinant health factors in the formation of uncontrolled type 2 diabetes mellitus The research is based on terabytes of area level data and claims data on over 1 million patients with Type 2 Diabetes Mellitus.

October 29, 2019
·
3 min read
BioMidwest

6 Skin Care Tips That Dermatologists Use Themselves; American Academy of Dermatology November is National Healthy Skin Month

Board-certified dermatologists are experts when it comes to the skin, hair and nails, diagnosing and treating more than 3,000 diseases and conditions, including skin cancer, acne, psoriasis and eczema.

October 29, 2019
·
5 min read
Business

BioTelemetry, Inc. to Release Third Quarter 2019 Earnings Results on November 5, 2019

BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time.

October 29, 2019
·
1 min read
BioMidwest

AARP’s Rx T. Rexes Roar Again on Capitol Hill and Around the Country: National Day of Action Urges Congress to Take a Bite Out of High Drug Prices

The Rx T. Rexes will visit offices on Capitol Hill today and make stops in all 50 states – including the Illinois Capitol and various legislative offices -- roaring about the need to lower prescription drug prices.

October 29, 2019
·
1 min read
Business

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019

Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the third quarter of 2019 after market close on Tuesday, November 12, 2019.

October 29, 2019
·
1 min read
Business

OpGen Announces Date of Third Quarter 2019 Financial Results Conference Call

OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its third quarter 2019 financial results after the close of the U.S. financial markets on Wednesday, November 6, 2019.

October 29, 2019
·
2 min read
Drug Development

Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that the Company is advancing the development of its MicroLine program for the improvement in near vision in patients with presbyopia towards Phase III development

October 29, 2019
·
8 min read
Business

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial ResultsConference Call Today at 4:30 p.m. ET / 1:30 p.m. PT

Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies, today provided a business update and reported financial results for the third quarter ended September 30, 2019.

October 29, 2019
·
11 min read
Business

Amedisys Reports Third Quarter 2019 Financial Results and Updates 2019 Guidance

Amedisys, Inc. reported its financial results for the three and nine-month periods ended September 30, 2019.

October 29, 2019
·
8 min read
Business

PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the third quarter ending September 30, 2019

October 29, 2019
·
15 min read